Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: EMR stock price vs ARCT: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ARCT's multiple
Needs ARCT P/E.
Implied fair value · at EMR's multiple
Needs EPS (TTM) is negative, EMR P/E.
Live quote
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: EMR FY 2025 (ended Sep 30, 2025) · ARCT FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
EMERSON ELECTRIC CO. · implied price per share
Bear
$40.65
Base
$47.83
Bull
$55.00
ARCTURUS THERAPEUTICS HOLDINGS INC. · implied price per share
Bear
-$2.12
Base
-$2.50
Bull
-$2.87
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.65x
0.47x
Net debt / EBITDA
Leverage against operating earnings
2.25x
2.04x
Cash and equivalents
Liquid reserves on the balance sheet
$2.45B
$230.91M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
HONEYWELL INTERNATIONAL INC
EMR vs HON
GENERAL ELECTRIC CO
EMR vs GE
DANAHER CORP /DE/
EMR vs DHR
Eaton Corp plc
EMR vs ETN
Moderna, Inc.
EMR vs MRNA
BioNTech SE
EMR vs BNTX
ALNYLAM PHARMACEUTICALS, INC.
EMR vs ALNY
Sarepta Therapeutics, Inc.
EMR vs SRPT
Intellia Therapeutics, Inc.
EMR vs NTLA
$13.12B
$101.29M
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
